ArticleTherapeutic advances in medical oncology2026

Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study).

Yasunori Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.